Abvc Pharma to spin off 15% of BioKey subsidiary
Parent company Abvc Pharma will distribute a 15% equity stake in BioKey (Cayman) to its shareholders, triggering a spin-off transaction.
View filing at SEC.gov →1 most recent filing and news item mentioning BIKY. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/BIKY/news?limit=20"
Pull BIKY filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayParent company Abvc Pharma will distribute a 15% equity stake in BioKey (Cayman) to its shareholders, triggering a spin-off transaction.
View filing at SEC.gov →